Warsaw, Ind.-based OrthoPediatrics reported preliminary unaudited third quarter 2025 net revenue of about $61.2 million, according to an Oct. 9 news release from the company.
Here are four more financial notes:
- Third quarter revenue in 2025 grew 12% compared to the third quarter of 2024, when the company brought in $54.6 million.
- Domestic revenue is expected to be about $48.7 million and international revenue is projected to be about $12.5 million for the third quarter.
- For the full year of 2025, OrthoPediatrics is expecting revenue between $233.5 million and $234.5 million.
- If the projection is accurate, the company’s 2025 revenue would be 14% to 15% higher than 2024.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
